Malignant Soft Tissue Neoplasm — Trials

Malignant Soft Tissue Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,396 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 341
Recruiting: 190
Ph III recruiting: 14
Growth YoY: −18.5%
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (200)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00233948	Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma	terminated	Phase 1 / Phase 2	29	City of Hope Medical CenterOTHER	1	Apr 1, 2015	clinicaltrials
NCT01786226	Mifepristone to Treat Uterine Fibroids	terminated	Phase 2 / Phase 3	220	Mediterranea Medica S. L.OTHER	1	Sep 5, 2014	clinicaltrials